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Introduction {#sec005}
============

The global burden of non-communicable disease (NCDs) has grown substantially in recent years, with the most rapid increase occurring in low- and middle-income countries (LMICs) \[[@pone.0226286.ref001]\]. This shifting landscape poses a significant challenge to health care systems, particularly in LMIC settings with limited infrastructure for addressing complex diseases such as diabetes which require coordinated care and long-term management. Globally, the prevalence of diabetes in adults has increased in every country since 1980, with the burden increasing most rapidly in LMICs \[[@pone.0226286.ref002]\]. The age standardized prevalence of diabetes globally has increased from four to nine percent for men, and from five to eight percent for women, which in absolute terms translates into an increase of 314 million more people with diabetes worldwide over the past 40 years \[[@pone.0226286.ref002]\]. Diabetes accounts for more than two million deaths a year, and is the seventh leading cause of disability worldwide \[[@pone.0226286.ref003]\].

Thailand has recently transitioned from a low middle income country to a high middle income country, with a GDP that more than tripled between 2000 and 2017, and is in the midst of an epidemiologic transition \[[@pone.0226286.ref004]\]. Chronic diseases were estimated to account for 74% of all deaths nationwide in 2016 \[[@pone.0226286.ref005]\]. By disease burden, diabetes was the leading cause for men, and the seventh cause for women in 2014 \[[@pone.0226286.ref006]\]. The age adjusted prevalence of diabetes increased from eight to ten percent from 2004 to 2014 in Thailand \[[@pone.0226286.ref007]\].

Thailand was one of the earliest LMIC to implement universal health insurance coverage in 2002, with over 99% of the population covered by one of three major insurance schemes \[[@pone.0226286.ref004]\]. With the growing burden of diabetes, expanded health systems under universal health coverage must also provide efficient and high quality care, as increased quantity of care alone has not resulted in healthier populations, satisfied patients, or equity of outcomes \[[@pone.0226286.ref008],[@pone.0226286.ref009]\]. Global standards around high quality healthcare in LMIC, including competent care, patient experience, health outcomes, and confidence in the system, remain markedly undeveloped \[[@pone.0226286.ref008]\]. Furthermore, there are a lack of data on where best to intervene to strengthen health systems to respond in particular to chronic diseases like diabetes \[[@pone.0226286.ref009]\].

One promising approach to addressing this challenge is the use of care cascades to identify points of loss, or gaps, in the chronic disease care continuum across screening, diagnosis, treatment, and control. Care cascades were originally used to model loss to follow up in HIV/AIDS care and have subsequently been applied to a range of other chronic conditions, including hypertension and diabetes \[[@pone.0226286.ref010],[@pone.0226286.ref011]\]. Prior studies using data across multiple LMIC, for example, revealed large gaps between screening and diagnosis, with 80% unmet need in diabetes care \[[@pone.0226286.ref012]--[@pone.0226286.ref014]\].

In the present study, we estimate national and regional levels of unmet need for care across the diabetes care continuum in Thailand using data from the Thai National Health Examination Survey (NHES-V). We hypothesize that sociodemographic and health-system factors both contribute to attrition across stages of the cascade, including diabetes screening, diagnosis, treatment, and control. The gaps identified by this approach may then be targets for future interventions to improve diabetes control, morbidity, and mortality in Thailand.

Methods {#sec006}
=======

Design, setting {#sec007}
---------------

This study used the 2014 Thai National Health Examination survey (NHES V), the largest cross-sectional, noninstitutionalized population representative survey in Thailand, completed every five years. The survey utilizes four stage sampling: 1) five provinces randomly selected from each of five regions, 2) two to three districts randomly selected from each province, 3) 24 enumeration areas randomly selected from each district (with balance of urban and rural), and 4) individuals of both sexes from each age group randomly selected from each enumeration area.

Data collection was conducted through face to face interviews, with a physical exam portion that collected blood samples after overnight fasting for eight hours. Blood samples were transferred to provincial hospitals for fasting plasma glucose testing using an enzymatic hexokinase method. All provincial laboratories were standardized to the central laboratory at the Department of Medical Service, Ministry of Public Health. In 2014, there were a total of 22,095 participants aged ≥20 years, and 8.8% adults had available blood samples \[[@pone.0226286.ref007]\].

Health system factors (hospitals, health centers, healthcare providers, and public health nurses) were abstracted from annual reports by the Policy and Strategy Bureau, and include both public and private hospitals \[[@pone.0226286.ref015]\]. These data were merged with NHES by province, the second subnational administrative level.

Participants {#sec008}
------------

All adults aged 20 and older, with a fasting plasma glucose were included \[[@pone.0226286.ref016],[@pone.0226286.ref017]\]. Participants with missing age, sex, religion, BMI or missing information on diabetes screening or diagnosis were excluded. We did not distinguish between type I and type II diabetes because care targets should not change based on the type of diabetes. A flow chart of study exclusions is presented in [S1 Fig](#pone.0226286.s001){ref-type="supplementary-material"}.

Measurements {#sec009}
------------

Diabetes was defined as a fasting plasma glucose ≥126mg/dL or on treatment for diabetes (oral glycemic medications in the last two weeks, insulin in the last two weeks, or lifestyle modification specifically for diabetes such as diet, exercise, or weight loss). Prediabetes was defined as anyone with a fasting plasma glucose ≥100 mg/dL and \<126, and not on treatment. Normoglycemia was defined as fasting plasma glucose \<100 and not on treatment.

For the care cascade, five mutually exclusive and exhaustive categories were created: 1) unscreened (fasting plasma glucose ≥126 mg/dL, never tested for high blood sugar or diabetes; no reported prior diagnosis) 2) screened, undiagnosed (fasting plasma glucose ≥126 mg/dL; reported being tested ever; no reported prior diagnosis of diabetes); 3) diagnosed, untreated (prior reported diagnosis of diabetes, but no reported current use of oral glycemic medication or insulin therapy or lifestyle modification); 4) treated, uncontrolled (reported current use of oral glycemic medication, insulin, or lifestyle modification with fasting plasma glucose ≥183 mg/dL); 5) treated, controlled (reported current use of diabetes medication or lifestyle modification with fasting plasma glucose \<183 mg/dL). A fasting plasma glucose of 183 corresponds to a HgbA1c 8% \[[@pone.0226286.ref014]\]. To examine loss across the cascade, we calculated the number of individuals with diabetes reaching each state of the cascade as a proportion of those reaching the prior stage. Unmet need was defined as the sum of first four categories (unscreened, undiagnosed, untreated, uncontrolled). [Fig 1](#pone.0226286.g001){ref-type="fig"} presents a visual depiction of the cascade model used in the present study. Care cascades were constructed for 1) total population, and 2) stratified by region.

![Diabetes care cascade framework.](pone.0226286.g001){#pone.0226286.g001}

The main outcomes of interest in this study were people with diabetes who were screened, diagnosed, treated, and controlled. Independent variables included region, individual factors (age, sex, BMI, highest educational level) and health system factors (healthcare provider density, hospital density, health center density). For region, we combined data from Bangkok and Central, given the city is nested within the region and the relatively small sample size. Age was included as a continuous variable in 10 year increments. Information on family history and treatment adherence could not be included due to the amount of missing data. For each health system factor, we first calculated the ratio of population per factor (eg number of providers) by province, and then standardized these ratios so that a one unit increase in the model for that variable would represent a one standard deviation increase from the mean. Medical staff included physicians and nurses. Public health nurses are a special cadre of nurses not involved in direct clinical care, but instead lead public health initiatives. We hypothesized a combination of both individual and health system factors contributed to attrition across cascade levels.

Statistical analysis {#sec010}
--------------------

To examine this attrition, we performed multivariable modeling using un-nested logistic regression. Based on initial analysis of the diabetes care cascade in the present study, we modeled the following outcomes: 1) probability of screening conditional on diabetes; 2) probability of diagnosis conditional on diabetes; 3) probability of control conditional on diabetes. We did not separately model treatment as the care cascade revealed nearly complete progression of the sample between diagnosis and treatment. In a secondary analysis, we used continuation ratio logit (CRL) regression, a method appropriate for modeling sequential processes in which outcomes are nested. A fully saturated CRL model is equivalent to a series of binary logit models implemented on each nested outcome. We modeled the following outcomes: 1) probability of screening conditional on diabetes; 2) probability of diagnosis conditional on screening; 3) probability of control conditional on diagnosis.

Survey data were weighted according to the inverse probability of being sampled based on the 2014 registered Thai population. The Thai 2010 Census was used for age standardization. All analyses were performed in Stata/SE 15.1 (StataCorp, College Station, TX). The family of svyset commands were used to adjust for survey weights \[[@pone.0226286.ref018]\].

Ethics {#sec011}
------

This research study was approved by the Thai Ministry of Health and the institutional review board at Mahidol University, Bangkok, Thailand as well as the institutional review board at Boston University School of Public Health. A waiver of consent was granted as no identifiable patient information was included.

Results {#sec012}
=======

A total of 15,663 adults greater than 20 years were included in this analysis ([Table 1](#pone.0226286.t001){ref-type="table"}). Participants tended to be middle aged (22.4% in 40--49 years, 24.0% in 50--59 years), female (52.4%), and normal BMI (53.4%). The majority of people had a primary education or less (57.7%), were overwhelming Buddhist (94.0%), and from rural areas (56.0%). About 17.3% of the sample was from Bangkok.

10.1371/journal.pone.0226286.t001

###### Demographic characteristics of analytic sample and prevalence of diabetes, NHES-V Thailand, 2014.

![](pone.0226286.t001){#pone.0226286.t001g}

                                                 Diabetes   
  ------------------------------- ------- ------ ---------- ------
  Age Standardized                               8.82       0.31
  Crude                                          11.1       0.34
  **Age (years)**                                           
  20--29                          1125    15.8   2.86       0.6
  30--39                          1751    17.4   4.71       0.61
  40--49                          3041    22.4   9.13       0.74
  50--59                          3418    24.0   15.5       0.83
  60--69                          3756    11.5   20.8       0.89
  70+                             2572    8.8    18.9       1.12
  **Sex**                                                   
  Female                          9102    52.4   9.26       0.43
  Male                            6561    47.6   8.28       0.45
  **BMI (kg/m2)**                                           
  Underweight                     1051    6.8    6.69       1.15
  Normal                          8135    53.4   8.91       0.44
  Overweight                      4863    28.7   14.5       0.68
  Obese                           1614    11     15.6       1.15
  **Religion**                                              
  Buddhist                        14649   94     8.96       0.33
  Not Buddhist                    1014    6      6.85       0.89
  **Highest Educational Level**                             
  Primary or less                 10293   57.7   10.0       0.77
  Low secondary                   1448    12.2   9.38       0.96
  High secondary or vocational    2444    19.3   7.47       0.63
  University                      1478    10.8   7.03       0.92
  **Geography**                                             
  Rural                           7416    56     9.06       0.47
  Urban                           8247    44     8.63       0.4
  **Region**                                                
  Bangkok                         3423    17.3   8.07       0.73
  South                           3753    27     6.11       0.5
  North                           3601    29.1   7.52       0.63
  Central                         2658    12.7   10.8       0.71
  Northeast                       2228    13.8   9.53       0.66
  Sample size                     15663          2255       

SE = standard error. BMI = body mass index. Sample weights were incorporated to adjust the percentage estimates in NHES-V sample for unequal probabilities of selection. BMI categories were: underweight (BMI \< 18.5 kg/m\^2), normal (18.5 ≤ BMI \< 25), overweight (25 ≤ BMI \< 30), and obese (BMI ≤ 30). Estimates for overall population and by sex, BMI, religion, educational level, geography, and region were age-standardized using five-year categories between 20--70+ using the 2010 Thai Census population estimates.

Prevalence of diabetes {#sec013}
----------------------

The age standardized prevalence of diabetes was 8.82% (95% CI 8.21% to 9.43%), and of prediabetes was 16.3% (95% CI 15.3 to 17.3) ([Table 1](#pone.0226286.t001){ref-type="table"}, [S1 Table](#pone.0226286.s003){ref-type="supplementary-material"}). There was a higher prevalence of both prediabetes and diabetes in older age groups, and higher BMI categories. While males had a higher prevalence of prediabetes compared to females (17.9% vs 14.9%), they had a slightly lower prevalence of diabetes (8.28% vs 9.26%). Diabetes prevalence declined slightly with increasing educational levels (10.0% for primary or less vs 7.03% for university). Lastly, between the regions, diabetes was most prevalent in Central (10.8%), and least prevalent in South (6.11%).

Diabetes care cascade {#sec014}
---------------------

[Fig 2](#pone.0226286.g002){ref-type="fig"} shows the diabetes care cascade. Among all people with diabetes, 67.0% (95% CI 60.9% to 73.1%) were screened, 34.0% (95% CI 30.6% to 37.4%) were diagnosed, 33.3% (95% CI 29.9% to 36.7%) were treated, and 26.0% (95% CI 22.9% to 29.1%) were controlled. The unmet need for diabetes was 74.0% (95% CI 70.9% to 77.1%). The largest gaps occurred at screening and diagnosis, while most people with diabetes who were diagnosed were on either lifestyle or medication treatment. In another way to examine this data, among the total population, approximately 8.82% or 6.0 million people had diabetes, 1.64% or 1.1 million had unscreened diabetes, 2.74% or 1.9 million had undiagnosed diabetes, and 0.85% or 0.6 million had uncontrolled diabetes ([S2 Table](#pone.0226286.s004){ref-type="supplementary-material"}).

![Diabetes care cascade, Thailand 2014.\
Point estimates are shown, with 95% confidence intervals in brackets. Among all people with diabetes, 67.0% were ever screened for diabetes (33.0% relative loss), 34.0% were ever diagnosed (49.3% loss), 33.3% were ever treated (2.0% loss), and 26.0% were controlled with fasting plasma glucose \<183 mg/dL (21.9% relative loss). Unmet need was 74.0% across the care cascade.](pone.0226286.g002){#pone.0226286.g002}

The diabetes care cascade, stratified by region, is shown in [Fig 3](#pone.0226286.g003){ref-type="fig"}. There is regional variation in cascade attrition. The largest gaps at screening and diagnosis occurred in Central (screening 38.7% \[95% CI 30.4% to 47.0%\], diagnosis 32.7% \[95% CI 29.1% to 36.3%\]) and Northeast regions (screening 28.9% \[95% CI 21.1% to 36.7%\], diagnosis 38.7% \[95% CI 32.6% to 44.8%\]), and the smallest occurred in South region (screening 16.9% \[91% CI 5.0% to 28.8%\], diagnosis 31.5% \[95% CI 18.5% to 44.5%\]). Unmet need ranged from 58.4% (95% CI 45.0% to 71.8%) in South to 78.0% (95% CI 73.0% to 83.0%) in Northeast region.

![Regional diabetes care cascade, Thailand 2014.\
Point estimates are shown, with 95% confidence interval bars. Within different regions (North, Central, Northeast, South, Bangkok), people with diabetes had different rates of attrition across the care cascade. Among people with diabetes, the Northeast had the lowest rates of control (21.8%), while South had the highest rates of control (47.9%).](pone.0226286.g003){#pone.0226286.g003}

Logistic regression to explore care cascade attrition {#sec015}
-----------------------------------------------------

We created regression models across the care continuum to understand if care cascade attrition was explained by individual level variables, or by health system level variables ([Table 2](#pone.0226286.t002){ref-type="table"}). Each ten-year increase in age was associated with a higher likelihood of being screened (OR 2.62, 95% CI 2.12 to 3.25), diagnosed (OR 1.76, 95% CI 1.56 to 1.98), and controlled (OR 1.80, 95% CI 1.61 to 2.01). Male sex was associated with decreased likelihood of all outcomes screened (OR 0.38, 95% CI 0.23 to 0.61) and diagnosed (OR 0.65, 95% CI 0.50 to 0.86), but not statistically significantly associated with controlled. There was a trend towards increased likelihood of screened, diagnosed, and controlled for increasing BMI, which was most pronounced for diagnosed and controlled. Lastly, two health system factors proved important related to outcomes, with variation of availability by region ([S2 Fig](#pone.0226286.s002){ref-type="supplementary-material"}). Increased density of medical staff was associated with higher likelihood of screened (OR 2.49, 95% CI 1.03 to 6.01), diagnosed (OR 2.40, 95% CI 1.41 to 4.08) and controlled (OR 1.82, 95% CI 1.10 to 2.99), and increased density of health centers, but not hospitals, was associated with higher likelihood of screened (OR 2.33, 95% CI 1.24 to 4.39), diagnosed (OR 1.58, 95% CI 1.12 to 2.24), and controlled (OR 1.56, 95% CI 1.13 to 2.15).

10.1371/journal.pone.0226286.t002

###### Factors associated with diabetes care cascade retention, Thailand 2014.

Un-nested logistic regression.

![](pone.0226286.t002){#pone.0226286.t002g}

                                                      Screened   Diagnosed   Controlled                                                                 
  --------------------------------------------------- ---------- ----------- ------------ --------- ------ ------ ------ --------- ------ ------ ------ ---------
  **Region**                                                                                                                                            
  Northeast                                           1                                             1                              1                    
  Bangkok + Central                                   0.60       0.30        1.20         0.15      0.84   0.56   1.27   0.42      1.18   0.80   1.75   0.40
  South                                               0.83       0.36        1.93         0.67      1.23   0.74   2.02   0.43      1.35   0.84   2.18   0.21
  North                                               0.74       0.38        1.44         0.37      1.01   0.68   1.5    0.97      1.36   0.92   2.00   0.12
  **Age**                                                                                                                                               
  Age in 10 year increments                           2.62       2.12        3.25         \<0.001   1.76   1.56   1.98   \<0.001   1.80   1.61   2.01   \<0.001
  **Sex**                                                                                                                                               
  Female                                              1                                             1                              1                    
  Male                                                0.38       0.23        0.61         \<0.001   0.65   0.5    0.86   0.002     0.81   0.63   1.05   0.12
  **BMI**                                                                                                                                               
  Underweight                                         0.46       0.17        1.21         0.12      0.53   0.24   1.17   0.12      0.53   0.24   1.14   0.10
  Normal                                              1                                             1                              1                    
  Overweight                                          2.35       1.39        3.98         0.001     1.58   1.17   2.13   0.003     1.47   1.11   1.94   0.007
  Obese                                               1.28       0.68        2.43         0.44      1.62   1.11   2.37   0.01      1.75   1.22   2.51   0.002
  **Highest Educational Level**                                                                                                                         
  Primary or Lower                                    1                                             1                              1                    
  Low Secondary                                       1.48       0.67        3.29         0.33      0.71   0.43   1.15   0.16      0.84   0.51   1.38   0.49
  High Secondary or Vocational                        1.95       0.94        4.05         0.07      0.99   0.63   1.55   0.96      1.10   0.71   1.69   0.67
  University                                          1.03       0.42        2.54         0.94      0.76   0.42   1.37   0.36      0.87   0.47   1.62   0.66
  **Geography**                                                                                                                                         
  Rural                                               1                                             1                              1                    
  Urban                                               0.92       0.56        1.51         0.74      0.90   0.68   1.19   0.46      0.85   0.64   1.12   0.25
  **Health System**                                                                                                                                     
  Hospital per Population, standardized               0.63       0.39        1.51         0.74      0.76   0.58   1.00   0.05      0.82   0.64   1.06   0.14
  Health Center per Population, Standardized          2.33       1.24        4.39         0.01      1.58   1.12   2.24   0.01      1.56   1.13   2.15   0.01
  Staff per Population, standardized                  2.49       1.03        6.01         0.04      2.40   1.41   4.08   0.001     1.82   1.10   2.99   0.02
  Public Health Nurses per Population, Standardized   0.94       0.53        1.67         0.84      0.71   0.50   1.00   0.05      0.79   0.57   1.09   0.15
  Subpopulation (n)                                   2255       2255        2255                                                                       

Multivariable adjusted odds ratios estimated using logistic regression with un-nested denominators at each stage. Analysis incorporated sample weights.

aOR = adjusted odds ratio. BMI = body mass index. BMI categories were: underweight (BMI \< 18.5 kg/m\^2), normal (18.5 ≤ BMI \< 25), overweight (25 ≤ BMI \< 30), and obese (BMI ≤ 30). For health system variables (population per hospital, population per staff, population per health center, population per public health nurses), values were standardized so a one unit increase represents a one standard deviation increase from the mean.

To examine which independent variables have statistically different coefficients across care cascade outcomes, we used the Brant test. Northeast region, age, sex, BMI, and density of hospitals, staff, and health centers had statistically different coefficients across screened, diagnosed, and treated ([S4 Table](#pone.0226286.s006){ref-type="supplementary-material"}).

In a sensitivity analysis with nested logistic regression, the outcome of diagnosed was similarly associated with age (OR 1.50, 95% CI 1.30 to 1.72), rising BMI, and density of medical staff (OR 2.17, 95% CI 1.24 to 3.81). For controlled, age (OR 1.59, 95% CI 1.32 to 1.91) remained significant, but health system factors did not.

Discussion {#sec016}
==========

This study had several key findings. First, we identified significant unmet need for diabetes care in the Thai adult population, with 74% of those with diabetes having an unmet need for care across levels of screening, diagnosis, treatment, or control. Second, the high unmet need for diabetes care was found to be largely attributable to loss at the stages of screening and diagnosis, which each contributed 33% to total unmet need. Third, although differences were not statistically significant, we found some suggestive evidence of regional variation in cascade performance, with unmet need ranging from 58.4% in South to 78.0% in the Northeast region. Fourth, across the sequential care cascade outcomes, we found that variation in cascade performance was explained both by demographic and health systems factors.

Our absolute losses of -33% at screening, and -66% at diagnosis in Thailand are slightly better for screening and slightly worse for diagnosis compared to other diabetes care cascade studies in South Africa (absolute losses -45% at screening, -60% at diagnosis), and globally in 28 low-and-middle income countries (absolute losses -37% at screening, -56% at diagnosis) \[[@pone.0226286.ref012]--[@pone.0226286.ref014]\]. The United States fares the worst among these cascades, with an absolute loss of -72% at diagnosis \[[@pone.0226286.ref016]\].

Earlier studies presented very low levels of unmet health care need in Thailand, at less than two percent of the population, based on individual subjective assessment of personal illness and utilization need \[[@pone.0226286.ref019],[@pone.0226286.ref020]\]. Given our 74.0% unmet need for only diabetes, we argue actual unmet health care need is much larger than previously reported, and requires objective assessment to complement subjective reports. Multiple factors contribute to Thailand's loss at screening and diagnosis. While Thailand has implemented universal coverage of health insurance since 2002 which reduced patient financial burdens and increased healthcare access, concerns remain around long wait times and low service quality in primary care settings, which may deter some patients from accessing screening and diagnosis \[[@pone.0226286.ref021]\]. Furthermore, early stages of diabetes can be asymptomatic, so that even if a patient attends a clinic visit, the physician must have a higher degree of suspicion to screen and diagnose diabetes, compared to symptomatic conditions that patients will mention themselves \[[@pone.0226286.ref022]\].

Regional variation in cascade progression was not significant in multivariable models, suggesting the differences may be due to a combination of demographic and health system factors. This has also been suggested in other studies examining geographic differences in health outcomes in Thailand, after implementation of universal health insurance. While overall mortality has steadily declined since 2002, the faster rate of decline in Bangkok compared to the North and Northeast regions has been surmised to be related to the higher poverty and lower health workforce density in the latter two regions \[[@pone.0226286.ref023]\]. This is consistent with our results, which showed that higher health staff density was associated with a higher OR of progressing through the cascade to diagnosis and control. Regional differences in the proportion of people on the Civil Servant Medical Benefit Scheme or Social Security Scheme (government employees and private sector, relatively high income) vs the Universal Coverage Scheme (informal employment sector, relatively low income), may also influence cascade progression as healthcare utilization and some medication access has shown to differ among the three insurance schemes \[[@pone.0226286.ref024],[@pone.0226286.ref025]\]. Due to small sample size, we were not able to examine interactions between region and health system factors. Additional studies are needed to better understand the extent to which regional variation in cascade performance in Thailand may be driven by regional differences in health system characteristics.

While care cascades are a useful way to measure quality and monitor progress at the health system level, there are many other socioeconomic, interpersonal, and structural factors in LMIC which influence good outcomes for diabetes and are not adequately captured, as conceptualized in the socio-ecologic model for health \[[@pone.0226286.ref026]\]. Political instability, lack of public infrastructure such as roads, cultural norms around food, barriers to meaningful physical activity, competing demands for limited resources at the individual level, and personal conceptual models of illness may all influence if a person develops diabetes, and how far through the cascade they progress. For example, in Thailand, one qualitative study explored how diabetes was viewed as a natural part of aging in the Buddhist life-course, which may impede treatment uptake \[[@pone.0226286.ref027]\]. Successful interventions will account for this complexity.

Our study highlights the need for stronger investment to strengthen primary health care in Thailand. An independent assessment after a decade of the Thai Universal Coverage Scheme (UCS) indicated that the focus on curative care may have contributed to lower resources for public health functions \[[@pone.0226286.ref028]\]. While several national policies to improve diabetes screening and care have been passed, and a dedicated "chronic care fund" was established under UCS to strengthen screening and primary care for diabetes and hypertension in 2011, large gaps remain in disease detection. Future steps might include expanding primary health care clinics and staff, in addition to auxiliary health providers like community pharmacists, who in prior studies have successfully managed diabetes and hypertension in conjunction with primary care providers. \[[@pone.0226286.ref021],[@pone.0226286.ref029]\]. Better health information systems that allow every Thai to access their personal health information, including diabetes risk and screening records, could also contribute to reducing unmet need.

This study had several limitations. First, we were unable to distinguish between type I and type II diabetes mellitus---however these conditions are not routinely disaggregated in other nationwide studies as the cascade targets are similar \[[@pone.0226286.ref016]\]. Additionally, in adult populations the overwhelming majority of people with diabetes are type II. Second, the single measurement of fasting plasma glucose may either overestimate the prevalence of diabetes if participants were not truly fasting, or underestimate it compared to an oral glucose tolerance test. A prior study in Thailand comparing fasting plasma glucose and the oral glucose tolerance test showed that fasting plasma glucose missed up to 46.3% of all prediabetes and 4.7% of all diabetes \[[@pone.0226286.ref030]\]. Third, participants with diabetes on treatment may be significantly more likely to report past diabetes screening or diagnosis, compared to participants with diabetes not on treatment. This would skew attrition to occur earlier (screening/diagnosis) rather than later (treatment/control). Fourth, given the cross-sectional study design, we were not able to examine the association of attrition across stages of the cascade with health outcomes or assess the temporal ordering of cascade steps. Therefore, it is possible that for some individuals, screening occurred prior to the development of diabetes, leading to an overestimate of attrition between the screening and diagnosis steps of the cascade. Future research should evaluate how unmet need for diabetes care affects progression to diabetes complications and associated health care costs through a prospective cohort.

In this nationally representative study, diabetes and prediabetes affected one in four adults over the age of 20 in Thailand. The care cascade is a helpful framework to understand where people with diabetes are lost in the healthcare system, with the largest drop offs at screening and diagnosis. Even with universal health insurance coverage, unmet need remained. Achieving screened, diagnosed, and controlled diabetes was more likely in older people, and in areas with increased density of medical staff or health centers. Future interventions should target increased screening and diagnosis of diabetes in Thailand.
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###### Prevalence of normoglycemia, prediabetes, and diabetes in Thailand, 2014.

SE = standard error. BMI = body mass index. Normoglycemia = fasting plasma glucose \< 100 mg/dL and not on treatment. Prediabetes = fasting plasma glucose ≥ 100 mg/dL and not on treatment. BMI categories were: underweight (BMI \< 18∙5 kg/m\^2), normal (18∙5 ≤ BMI \< 25), overweight (25 ≤ BMI \< 30), and obese (BMI ≤ 30). Estimates for overall population and by sex, BMI, religion, educational level, geography, and region were age-standardized using five-year categories between 20--70+ using the 2010 Thai Census population estimates.
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###### Prevalence of unscreened, undiagnosed, untreated, and uncontrolled diabetes, among total Thai population 2014.

SE = standard error. BMI = body mass index. BMI categories were: underweight (BMI \< 18∙5 kg/m\^2), normal (18∙5 ≤ BMI \< 25), overweight (25 ≤ BMI \< 30), and obese (BMI ≤ 30). Estimates for overall population and by sex, BMI, religion, educational level, geography, and region were age-standardized using five-year categories between 20--70+ using the 2010 Thai Census population estimates. Source: NHES-V
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###### Factors associated with diabetes care cascade retention, Thailand 2014.

**Nested logistic regression.** Multivariable adjusted odds ratios estimated using continuation ratio logit model with coefficients freely varying across stages. Analysis incorporated sample weights. aOR = adjusted odds ratio. BMI = body mass index. BMI categories were: underweight (BMI \< 18∙5 kg/m\^2), normal (18∙5 ≤ BMI \< 25), overweight (25 ≤ BMI \< 30), and obese (BMI ≤ 30). For health system variables (hospitalization per population, staff per population, health center per population, public health nurses per population), values were standardized so a one unit increase represents a one standard deviation increase from the mean. Source: NHES-V.

(DOCX)

###### 

Click here for additional data file.

###### Brant test on independent variable coefficients across outcomes of screened, diagnosed, and controlled.

Brant test of parallel regression assumption tests whether coefficients for a specific independent variable is statistically different across sequential ordinal outcomes, in this case screened, diagnosed, or controlled diabetes. The null hypothesis is that all coefficients are the same. P values \> 0∙05 indicate the null hypothesis is true, ie coefficients are the same across outcomes. P values \<0∙05 indicate evidence to reject the null hypothesis, ie coefficients are different across outcomes.

(DOCX)

###### 

Click here for additional data file.

###### STROBE checklist.

STROBE checklist for cross-sectional studies.

(DOC)

###### 

Click here for additional data file.
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Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please carefully consider each of the concerns raised by the reviewers in revising the manuscript.
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Kind regards,
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<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

1\. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.
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Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: No

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: No

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: No

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The research question and the idea of the paper are interesting and relevant. However, the statistical implementation and interpretation of empirical results are erroneous for multiple reasons:

1\) The diabetes care cascades are missing confidence intervals or any measure of precision. Therefore, no conclusions about differences across cascade stages should be made.

2\) Point 1 also applies to regional differences at different cascade stages. Point estimates seem to suggest differences across regions, but the reader remains clueless whether the differences are statistically meaningful.

3\) From the text and the table, it is not exactly clear how the estimation specification was set-up. For example, there is no mention that regional fixed effects were included. However, in the conclusion the authors mention that regions were not significant in the regression analysis. While this point regards transparency it also withholds the reader relevant information - the coefficients on regions are of interest and should be included in table 2. Further, the choice of using a continuous 10-year age increment variable rather than 10-year age bracket fixed effects is not comprehensible.

4\) These first 4 points reduce the credibility of the claims made in the first discussion paragraph.

5\) Confidence intervals and/or p-values are not included in the text.

6\) The study mentions some \"preliminary analysis of diabetes\", however, it remains unknown what this analysis entails.

In Addition, there are some conceptual aspects which could improve the analysis - where the first point is of much greater relevance than the second one.

1\) The most interesting aspect of the paper is the regional variation in health system performance. However, the authors do not at all tease out this point to the extent possible. For example, the inclusion of interactions of health system factors and regional indicators in the regression model, would create much more detailed insights into relevant health system factors across regions to explain the considered losses. While this may look messy in a regression output table, such comparisons may be nicely visualized.

2\) The NHES-V is a repeated survey. In order to explore the impact of universal health coverage, the authors might want to look at the evolution of care cascades over time.

Reviewer \#2: The authors worked on an interesting topic and on a large database. The paper is well structured. The methodology is clear. The results are presented with interesting details. However, they could improve the quality of their paper.

Comments

\--Lines 218-223 : Harmonize the numbers on Chart A and in the legend

\--Line 217 : Supplementary Table 2 : I suggest to the authors to present the cascade levels : screened, diagnosed, treated and controlled, instead of the opposite. It will facilitate the analysis of the other results, especially the table 2.

I also suggest them to present p-value in table 2 to better describe the raw relationship between variables and cascade levels. This will allow a better understanding the discussion on multivariate analysis \"Regional variation in cascade progression was not significant after multivariable adjustment\... \".

\--Lines 333-335 \"Second, the single measurement of fasting plasma glucose may not have captured all people with diabetes, and underestimate the prevalence of diabetes...all diabetes.

The authors should qualify their assertions. Failure to perform an oral tolerance glucose test for prediabetics may underestimate the frequency of diabetes as they mentioned. Taking into account of a single measure could rather overestimate this frequency. Some participants could have not respected fasting for the first measure.

\-\--The authors showed that the maximum attrition was on the diagnosis level. In the discussion (line 335-340), they could more discuss clearly this result because the model of the cascade has some limits. The status of the participant may have changed between the last screening and the date of the diagnosis performed by the study. Being screened, but undiagnosed may not be only linked to the health system weakness.

\-\--There are some points in the cascade the authors could compare with results from other regions. Almost all people diagnosed had been ever treated and nearly three-quarters of those treated had a fasting plasma glucose level of less than 1.83 g / l. These results seem better than others.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Reviewer Comments to the Author

Reviewer \#1: The research question and the idea of the paper are interesting and relevant. However, the statistical implementation and interpretation of empirical results are erroneous for multiple reasons:

1\) The diabetes care cascades are missing confidence intervals or any measure of precision. Therefore, no conclusions about differences across cascade stages should be made.

a\. RESPONSE: Thank you for your suggestion. We have modified Fig2 to include not only the point estimate, but also the 95% confidence interval for each stage. We have also edited the text in the Results section to reflect this.

b\. Lines 216-219: Figure 2 shows the diabetes care cascade. Among all people with diabetes, 67.0% (95% CI 60.9% to 73.1%) were screened, 34.0% (95% CI 30.6% to 37.4%) were diagnosed, 33.3% (95% CI 29.9% to 36.7%) were treated, and 26.0% (95% CI 22.9% to 29.1%) were controlled. The unmet need for diabetes was 74.0% (95% CI 70.9% to 77.1%).

2\) Point 1 also applies to regional differences at different cascade stages. Point estimates seem to suggest differences across regions, but the reader remains clueless whether the differences are statistically meaningful.

a\. RESPONSE: Thank you. We have modified Fig3 to also include the 95% confidence intervals as error bars, and edited the associated text.

b\. Lines 232-238: The diabetes care cascade, stratified by region, is shown in Figure 3. There is regional variation in cascade attrition. The largest gaps at screening and diagnosis occurred in Central (screening 38.7% \[95% CI 30.4% to 47.0%\], diagnosis 32.7% \[95% CI 29.1% to 36.3%\]) and Northeast regions (screening 28.9% \[95% CI 21.1% to 36.7%\], diagnosis 38.7% \[95% CI 32.6% to 44.8%\]), and the smallest occurred in South region (screening 16.9% \[91% CI 5.0% to 28.8%\], diagnosis 31.5% \[95% CI 18.5% to 44.5%\]). Unmet need ranged from 58.4% (95% CI 45.0% to 71.8%) in South to 78.0% (95% CI 73.0% to 83.0%) in Northeast region.

3\) From the text and the table, it is not exactly clear how the estimation specification was set-up. For example, there is no mention that regional fixed effects were included. However, in the conclusion the authors mention that regions were not significant in the regression analysis. While this point regards transparency it also withholds the reader relevant information - the coefficients on regions are of interest and should be included in table 2.

a\. RESPONSE: Thank you. In the Methods text, although we listed other independent variables, we did neglect to explicitly list "region" and "education". We have corrected this (see "b" below). The reviewer mentions that the coefficients on regions are not included in Table 2. However, in Table 2 we did include all of the independent variables (line 254). Perhaps some of the confusion comes from the fact that we combined Bangkok (the city) and Central (the region). This combination was suggested specifically by Dr Wichai Aekplakorn, who is one of the principal researchers on NHES and very familiar with the survey design and rollout. Given the location of Bangkok within Central, and small sample size with Bangkok, we have combined the two. We have added a section to the Methods text to explicitly mention this (see "c" below).

b\. Lines 155-162: The main outcomes of interest in this study were people with diabetes who were screened, diagnosed, treated, and controlled. Independent variables included region, individual factors (age, sex, BMI, highest educational level) and health system factors (healthcare provider density, hospital density, health center density). Information on family history and treatment adherence could not be included due to the amount of missing data.

c\. Lines 158-160: For region, we combined data from Bangkok and Central, given the city is nested within the region and the relatively small sample size.

4\) Further, the choice of using a continuous 10-year age increment variable rather than 10-year age bracket fixed effects is not comprehensible.

a\. RESPONSE: We apologize for the confusion. We have simply rescaled the continuous age variable so that the adjusted odds ratio in the model corresponds to a 10-unit increase in age as opposed to a 1-unit increase in age. Other than affecting the interpretation of the beta coefficient, the rescaling does not affect the model results. We have adjusted the text to clarify this point.

b\. Line 160: Age was included as a continuous variable in 10 year increments.

5\) These first 4 points reduce the credibility of the claims made in the first discussion paragraph.

a\. RESPONSE: We hope that addressing the concerns above will improve the interpretability of our Results, and the credibility of our Discussion. We have tempered the language about the regional trends, as not all the differences were statistically different.

b\. Lines 282-285: Third, although differences were not statistically significant, we found some suggestive evidence of regional variation in cascade performance, with unmet need ranging from 58.4% in South to 78.0% in the Northeast region.

6\) Confidence intervals and/or p-values are not included in the text.

a\. RESPONSE: Thank you. Please see above for modifications to include confidence intervals in the text for the care cascades. For the regressions, to avoid duplication of text and table, we did not originally include confidence intervals. However, per your suggestion, we have now included all 95% CI for reported odds ratios.

b\. Examples, lines 247 to 250: Each ten-year increase in age was associated with a higher likelihood of being screened (OR 2.62, 95% CI 2.12 to 3.25), diagnosed (OR 1.76, 95% CI 1.56 to 1.98), and controlled (OR 1.80, 95% CI 1.61 to 2.01).

7\) The study mentions some \"preliminary analysis of diabetes\", however, it remains unknown what this analysis entails.

a\. RESPONSE: Thank you for your point. The preliminary analysis was the care cascade presented in Figure 2. We have edited the text in the Methods section to clarify this.

b\. Line 174-176: Based on initial analysis of the diabetes care cascade in the present study, we modeled the following outcomes: 1) probability of screening conditional on diabetes; 2) probability of diagnosis conditional on diabetes; 3) probability of control conditional on diabetes.

c\. Line 177-178: We did not separately model treatment as the care cascade preliminary analysis revealed nearly complete progression of the sample between diagnosis and treatment.

In Addition, there are some conceptual aspects which could improve the analysis - where the first point is of much greater relevance than the second one.

1\) The most interesting aspect of the paper is the regional variation in health system performance. However, the authors do not at all tease out this point to the extent possible. For example, the inclusion of interactions of health system factors and regional indicators in the regression model, would create much more detailed insights into relevant health system factors across regions to explain the considered losses. While this may look messy in a regression output table, such comparisons may be nicely visualized.

a\. RESPONSE: Thank you for your suggestion. Including an interaction of health system factors (4) with regions (4 with Bangkok+Central combined) would result in 16 interaction terms. Given our sample size of 2255 people with diabetes in the NHES survey, many of these cells would have too few people for the coefficients to be meaningful. However, we have incorporated a plot of the number of hospitals, stand alone health clinics, doctors, nurses, and public health nurses by region in a new Supplemental Figure 2 and include reference to it in the text.

b\. Lines 254-255: Lastly, two health system factors proved important related to outcomes, with variation of availability by region (Supplemental Figure 2).

c\. Lines 317-321: Due to small sample size, we were not able to examine interactions between region and health system factors. Additional studies are needed to better understand the extent to which regional variation in cascade performance in Thailand may be driven by regional differences in health system characteristics.

2\) The NHES-V is a repeated survey. In order to explore the impact of universal health coverage, the authors might want to look at the evolution of care cascades over time.

a\. RESPONSE: Thank you for your suggestion. We agree that longitudinal analysis would better capture the effect of universal health coverage, and consider it a promising avenue for future research.

Reviewer \#2: The authors worked on an interesting topic and on a large database. The paper is well structured. The methodology is clear. The results are presented with interesting details. However, they could improve the quality of their paper.

Comments

1\) Lines 218-223 : Harmonize the numbers on Chart A and in the legend

a\. RESPONSE: Thank you for pointing this out. We have corrected the outdated legend numbers to match the Figure 2 values.

b\. Lines 227-230: Point estimates are shown, with 95% confidence intervals in brackets. Among all people with diabetes, 67.03% were ever screened for diabetes (33.02.7% relative loss), 34.06% were ever diagnosed (49.38.6% loss), 33.39% were ever treated (2.0% loss), and 26.03% were controlled with fasting plasma glucose \<183 mg/dL (21.92.4% relative loss). Unmet need was 74.03.7% across the care cascade.

2\) Line 217 : Supplementary Table 2 : I suggest to the authors to present the cascade levels : screened, diagnosed, treated and controlled, instead of the opposite. It will facilitate the analysis of the other results, especially the table 2.

a\. RESPONSE: Thank you for your suggestion. The rationale behind choosing to display unscreened, undiagnosed, untreated, uncontrolled, and controlled in Supplementary Table 2 is to show the mutually exclusive and exhaustive cascade categories of diabetes. The absolute percentages shown in the age-standardized line add up to the overall prevalence of diabetes in Thailand (8.8%). This also focuses on unmet need, and complements the main presentation of the data.

3\) I also suggest them to present p-value in table 2 to better describe the raw relationship between variables and cascade levels. This will allow a better understanding the discussion on multivariate analysis \"Regional variation in cascade progression was not significant after multivariable adjustment\... \".

a\. RESPONSE: Thank you for your suggestion. Table 2 (line 259) does have the p values displayed, in the column labeled "p". As this did not seem to be clear, we have revised the column title from "p" to "p-value".

b\. Line 261 Table 2

4\) Lines 333-335 \"Second, the single measurement of fasting plasma glucose may not have captured all people with diabetes, and underestimate the prevalence of diabetes...all diabetes." The authors should qualify their assertions. Failure to perform an oral tolerance glucose test for prediabetics may underestimate the frequency of diabetes as they mentioned. Taking into account of a single measure could rather overestimate this frequency. Some participants could have not respected fasting for the first measure.

a\. RESPONSE: Thank you, we have incorporated your suggestion.

b\. Line 347-350: Second, the single measurement of fasting plasma glucose may either overestimate the prevalence of diabetes if participants were not truly fasting, or underestimate it compared to an oral glucose tolerance test.

5\) The authors showed that the maximum attrition was on the diagnosis level. In the discussion (line 335-340), they could more discuss clearly this result because the model of the cascade has some limits. The status of the participant may have changed between the last screening and the date of the diagnosis performed by the study. Being screened, but undiagnosed may not be only linked to the health system weakness.

a\. RESPONSE: We agree. A patient who has been screened in the past (years ago) may have developed diabetes between then and the date of the survey, without intervening screening in between. We have attempted to describe this limitation more clearly.

b\. Line 355-360: Fourth, given the cross-sectional study design, we were not able to examine the association of attrition across stages of the cascade with health outcomes or assess the temporal ordering of cascade steps. Therefore, it is possible that for some individuals, screening occurred prior to the development of diabetes, leading to an overestimate of attrition between the screening and diagnosis steps of the cascade.

6\) There are some points in the cascade the authors could compare with results from other regions. Almost all people diagnosed had been ever treated and nearly three-quarters of those treated had a fasting plasma glucose level of less than 1.83 g / l. These results seem better than others.

a\. RESPONSE: We have compared our care cascade results with other diabetes care cascades in South Africa, 28 other low and middle income countries, and the United States.

b\. Lines 287-292: Our absolute losses of -33% at screening, and -66% at diagnosis in Thailand are slightly better for screening and slightly worse for diagnosis compared to other diabetes care cascade studies in South Africa (absolute losses -45% at screening, -60% at diagnosis), and globally in 28 low-and-middle income countries (absolute losses -37% at screening, -56% at diagnosis) \[12--14\]. The United States fares the worst among these cascades, with an absolute loss of -72% at diagnosis \[16\].
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Dear Dr. Stokes,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Nayu Ikeda, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#2: (No Response)

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#2: The authors have improved their manuscript. They have improved the tables presentation and the discussion. It could be published.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#2: No

10.1371/journal.pone.0226286.r004

Acceptance letter

Ikeda

Nayu

Academic Editor

© 2020 Nayu Ikeda

2020

Nayu Ikeda

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

2 Dec 2019

PONE-D-19-22038R1

Universal coverage but unmet need: national and regional estimates of attrition across the diabetes care continuum in Thailand

Dear Dr. Stokes:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.
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